Mesenchymal Stem Cells Market: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Mesenchymal Stem Cells Market By Source (Bone Marrow, Peripheral Blood, Lung Tissue, Umbilical Cord Blood, Amniotic Fluids, Adipose Tissues, and Synovial Tissues), By Applications (Injuries, Drug Discovery, Cardiovascular Infraction and Others), By End User (Clinical Research Organizations, Biotechnological Companies, Medical Research Institutes, and Hospitals), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global Mesenchymal Stem Cells Market Report Description:

Global mesenchymal stem cells market report gives comprehensive outlook on mesenchymal stem cells across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of source, application, end user, and region. This report studies global mesenchymal stem cells market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global mesenchymal stem cells market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global mesenchymal stem cells products.

 

Global Mesenchymal Stem Cells Market:

The global mesenchymal stem cells market estimated to be valued US$ XX Mn in 2019 and poised to grow at significant CAGR over 2020-2026 owing to increase in the prevalence of chronic diseases, degenerative, inflammatory, and autoimmune diseases. Scientific advancements and rising number of biotechnological companies across the globe are expected to propel the growth of the market. Additionally, enhancing application of mesenchymal stem cells for the treatment of chronic diseases, bone and cartilage diseases, and autoimmune diseases, the advantages of mesenchymal stem cells such as ease of isolation, high potential of regeneration and immunoregulatory nature and increasing demand for advanced healthcare facilities are expected to enhance the sale of mesenchymal stem cells market.

 

North America Holds the Highest Market Revenue Share in Global Mesenchymal Stem Cells Market

North America accounted for larger revenue share in global mesenchymal stem cells market with significant CAGR owing to increasing number of research activities and advancements in technologies, availability of skilled personnel and advanced research facilities and presence of leading market players in the region are expected to increase the growth of the market over the forecasted years. Asia Pacific region is expected to grow at a significant growth rate over the forecast years owing to the enhanced healthcare infrastructure, and presence of large patient pool.

 

Competition Assessment

  • Cell Applications, Inc. (USA)
  • Celprogen, Inc. (USA)
  • Cyagen US Inc. (USA)
  • Genlantis, Inc. (USA)
  • Lonza Group (Switzerland)
  • Mesoblast Limited (Australia)
  • MilliporeSigma (USA)
  • Neuromics (USA)
  • Orthofix International N.V. (Italy)
  • PromoCell GmbH (Germany)

 

Key Findings of the Report:

 

  • Global market expanding at significant CAGR over 2020 to 2026 owing to rising prevalence of chronic disorders and rising advancements in technology for the development of new products and drugs
  • Based on application, cardiovascular segment of mesenchymal stem cells accounted for larger market revenue share in 2019 and projected to gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market

 

Detailed Segmentation

 

By Source of Isolation

 

  • Bone Marrow
  • Umbilical Cord Blood
  • Peripheral Blood
  • Lung Tissue
  • Synovial Tissues
  • Amniotic Fluids
  • Adipose Tissues

By Applications  

 

  • Injuries
  • Drug Discovery
  • Cardiovascular Infraction
  • Others

By End User  

 

  • Clinical research organizations
  • Biotechnological companies,
  • Medical research institutes,
  • Hospitals

 

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

Description

Global Mesenchymal Stem Cells Market Report Description:

Global mesenchymal stem cells market report gives comprehensive outlook on mesenchymal stem cells across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The report on global market gives historical, current, and future market sizes (US$ Mn) on the basis of source, application, end user, and region. This report studies global mesenchymal stem cells market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the global mesenchymal stem cells market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global mesenchymal stem cells products.

 

Global Mesenchymal Stem Cells Market:

The global mesenchymal stem cells market estimated to be valued US$ XX Mn in 2019 and poised to grow at significant CAGR over 2020-2026 owing to increase in the prevalence of chronic diseases, degenerative, inflammatory, and autoimmune diseases. Scientific advancements and rising number of biotechnological companies across the globe are expected to propel the growth of the market. Additionally, enhancing application of mesenchymal stem cells for the treatment of chronic diseases, bone and cartilage diseases, and autoimmune diseases, the advantages of mesenchymal stem cells such as ease of isolation, high potential of regeneration and immunoregulatory nature and increasing demand for advanced healthcare facilities are expected to enhance the sale of mesenchymal stem cells market.

 

North America Holds the Highest Market Revenue Share in Global Mesenchymal Stem Cells Market

North America accounted for larger revenue share in global mesenchymal stem cells market with significant CAGR owing to increasing number of research activities and advancements in technologies, availability of skilled personnel and advanced research facilities and presence of leading market players in the region are expected to increase the growth of the market over the forecasted years. Asia Pacific region is expected to grow at a significant growth rate over the forecast years owing to the enhanced healthcare infrastructure, and presence of large patient pool.

 

Competition Assessment

  • Cell Applications, Inc. (USA)
  • Celprogen, Inc. (USA)
  • Cyagen US Inc. (USA)
  • Genlantis, Inc. (USA)
  • Lonza Group (Switzerland)
  • Mesoblast Limited (Australia)
  • MilliporeSigma (USA)
  • Neuromics (USA)
  • Orthofix International N.V. (Italy)
  • PromoCell GmbH (Germany)

 

Key Findings of the Report:

 

  • Global market expanding at significant CAGR over 2020 to 2026 owing to rising prevalence of chronic disorders and rising advancements in technology for the development of new products and drugs
  • Based on application, cardiovascular segment of mesenchymal stem cells accounted for larger market revenue share in 2019 and projected to gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global market

 

Detailed Segmentation

 

By Source of Isolation

 

  • Bone Marrow
  • Umbilical Cord Blood
  • Peripheral Blood
  • Lung Tissue
  • Synovial Tissues
  • Amniotic Fluids
  • Adipose Tissues

By Applications  

 

  • Injuries
  • Drug Discovery
  • Cardiovascular Infraction
  • Others

By End User  

 

  • Clinical research organizations
  • Biotechnological companies,
  • Medical research institutes,
  • Hospitals

 

Geography

 

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Key Features of the Report:

 

  • The report provides granular level information about the market size, regional market share, historic market (2015-2019) and forecast (2020-2026)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market


Location

GEOGRAPHY

PBI Location Map

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX